Process intensification in the pharmaceutical industry has led to the development of smaller and more compact equipment. With the goal of achieving more consistent process control and, ultimately, higher quality end products, manufacturers are increasingly moving away from batch-based systems and switching to CM. Providing increased yields, lower utility consumption and reduced waste, continuous manufacturing presents a paradigm shift in drug production and meets the industry’s demands for faster product development, reduced costs, improved production economics and increased manufacturing flexibility.
Other content from GEA Group
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation